Effecty offers compounded NAD+ injections through online clinical review and home delivery. Its current injection page advertises a starting monthly equivalent of $160, but the footnote ties that figure to purchasing a twelve-month supply. The monthly plan displayed on the same page is $225.
This review examines the current NAD+ offer checked September 19, 2026. An older promotional URL returned a missing-page response during our research, so we used the live longevity product page. We have not purchased from Effecty, and the review does not claim personal experience of its medication or support.
The lowest Effecty monthly equivalent requires a twelve-month purchase. Compare the full payment and refund terms with shorter plans before committing.
Four plan lengths, four different commitments
The current injection page displays monthly equivalents of $225 for a monthly plan, $195 for three months, $175 for six months, and $160 for twelve months. It describes billing at the corresponding intervals. The smallest displayed monthly figure therefore comes with the longest financial commitment.
At those advertised rates, twelve months represents $1,920 before any order-specific adjustment, whereas the three-month equivalent represents $585. Confirm the checkout total, delivery schedule, and renewal terms rather than assuming a monthly installment. The cost guide explains why a lower monthly equivalent can still be a harder purchase to reverse.
What Effecty says is included
The offer says plans include supplies, shipping, a prescription if eligible, and continuing medical support without a membership fee. It describes an online intake and review by a licensed provider. These are concrete elements to confirm on the selected order, separate from the website’s claims about energy, cognition, and aging.
Ask how much medication is dispatched at one time and how future shipments are authorized. Paying for a long plan should not mean receiving a supply that outlasts its labeled usability. Get a clear explanation of what happens if the clinician changes the prescription or decides that continued treatment is not appropriate.
A nasal spray is a separate comparison
Effecty also markets an NAD+ nasal spray. Its price, packaging, and instructions should be evaluated independently from the injection plan. Choosing between the two requires a clinical conversation about the actual preparation and the practical demands of each route; a shared ingredient name does not make them equivalent products.
Our injections-versus-nasal-spray guide explains the questions to ask. If avoiding needles is the priority, compare the Fridays review and Midi Health review as well. Neither provides evidence that a spray will reproduce the effect of a prescribed injection.
Support access should have a practical meaning
Effecty advertises secure messaging and continuing care. Before subscribing, ask whether medication questions reach a clinician, the expected response time, and what telephone or video help is available if written instructions are difficult to follow. An around-the-clock messaging inbox does not necessarily mean an immediate clinical appointment.
Discuss how to report a delayed shipment or a vial that arrives with unclear labeling. You need both medical follow-up and a pharmacy contact who can address the dispensed preparation. The consultation checklist is a useful way to capture these answers before the purchase becomes a recurring commitment.
Review the evidence before buying a year
Effecty’s page describes potential wellness benefits and also acknowledges the compounded product’s lack of FDA approval. A long purchase period is a billing choice, not evidence that twelve months is medically necessary or that a particular benefit will occur. Ask what measurable reason would justify continuing the plan.
The NAD+ evidence guide separates biological interest from confirmed outcomes with a specific formulation. Public customer comments may describe good service or perceived improvement, but they are not a controlled test. This matters especially when a discounted plan asks you to commit well beyond an initial clinical reassessment.
Compare flexibility alongside the headline savings
The Brello review examines another prepaid offer with a different renewal interval. The Strut Health review covers a monthly refill model and a published processing cutoff. Comparing cancellation timing, shipment timing, and total payment makes those offers more understandable than ranking them by one price card.
Our CoreAge Rx review provides another online-service reference and discloses our commercial relationship. Effecty’s current price ladder is useful, but a reader should still obtain the full order terms. The right question is whether the clinical plan and financial commitment are both acceptable, not whether the largest discount looks attractive.
Follow the source
References & further reading
- Effecty — current NAD+ injectable offer
Checked September 19, 2026. Current monthly and prepaid price ladder. The former promotional URL returned 404 and was not used as the current offer.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.